Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Nov 21, 2018
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new robotic arm designed to help people recover movement in their arms after having a stroke. The goal is to see how effective this robotic device is in improving upper limb rehabilitation for patients. The trial will include individuals who are either in the early stages of recovery (less than six months since their stroke) or those who are further along in their recovery (more than six months post-stroke). Both men and women aged between 25 and 75 years are welcome to participate, as long as they meet certain health criteria.
To be eligible for the study, participants should be able to sit up for at least an hour and have a specific level of arm movement ability. Those with severe language difficulties, certain medical conditions, or who are pregnant cannot join the trial. If you participate, you can expect to use the robotic arm during rehabilitation sessions and contribute to research that could help improve recovery options for stroke survivors in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For the subacute groups:
- • Two weeks after the onset of stroke, however less than 0.5 year
- • Mini-Mental State Examination (MMSE)\>21
- • Able to sit up for at least 1 hour
- • Fugl-Meyer Assessment (FMA) upper limb \<30
- • Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3
- • Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline)
- For the chronic device assisted group:
- • At least 0.5 year after the onset of stroke
- • Mini-Mental State Examination (MMSE)\>21
- • Able to sit up for at least 1 hour
- • Fugl-Meyer Assessment (FMA) upper limb \<30
- • Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3
- • Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline)
- Exclusion Criteria:
- Subjects will be excluded if they do not meet the above inclusion criteria, or had the following conditions:
- • Currently pregnant
- • Dysphasia (language deficiency)
- • Post-stroke neglect
- • Pacemaker implantation,
- • Involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb
- • The overall medical condition not suitable for the training (e.g., severe cardiac problem, unstable blood pressure, etc.).
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials